HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sung-Bae Kim Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

7/2021Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
10/2020Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
10/2019First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sung-Bae Kim Research Topics

Disease

160Breast Neoplasms (Breast Cancer)
05/2024 - 06/2004
100Neoplasms (Cancer)
04/2024 - 02/2003
24Disease Progression
03/2024 - 11/2007
20Esophageal Squamous Cell Carcinoma
10/2023 - 01/2003
20Squamous Cell Carcinoma of Head and Neck
09/2023 - 04/2005
18Triple Negative Breast Neoplasms
01/2024 - 07/2011
18Esophageal Neoplasms (Esophageal Cancer)
07/2022 - 10/2004
17Neutropenia
02/2022 - 05/2012
17Neoplasm Metastasis (Metastasis)
12/2021 - 11/2007
13Pathologic Complete Response
01/2023 - 06/2007
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 05/2007
10Fatigue
11/2023 - 05/2007
10Carcinoma (Carcinomatosis)
10/2023 - 01/2005
9Head and Neck Neoplasms (Head and Neck Cancer)
10/2023 - 05/2010
8Deglutition Disorders (Dysphagia)
10/2023 - 01/2005
8Pathologic Constriction (Stenosis)
03/2018 - 03/2002
7Interstitial Lung Diseases (Interstitial Lung Disease)
01/2023 - 11/2019
7Body Weight (Weight, Body)
01/2020 - 04/2004
6Adenoid Cystic Carcinoma (Cylindroma)
04/2024 - 06/2013
6Pneumonia (Pneumonitis)
01/2023 - 05/2013
6Diarrhea
02/2022 - 01/2012
6Fistula
07/2013 - 03/2002
5Brain Neoplasms (Brain Tumor)
12/2022 - 10/2008
5Thrombocytopenia (Thrombopenia)
10/2020 - 06/2014
5Febrile Neutropenia
01/2020 - 01/2012
5Pain (Aches)
02/2008 - 03/2002
4Infections
06/2023 - 11/2010
4Nausea
01/2023 - 05/2007
4Hypersensitivity (Allergy)
01/2021 - 06/2011
4Residual Neoplasm
01/2019 - 05/2014
4Multiple Myeloma
09/2005 - 12/2002
3Vomiting
01/2023 - 05/2007
3Adenocarcinoma
07/2022 - 04/2019
3Stomach Neoplasms (Stomach Cancer)
12/2021 - 10/2019
3Exanthema (Rash)
07/2021 - 12/2013
3Inflammation (Inflammations)
01/2021 - 06/2013

Drug/Important Bio-Agent (IBA)

45Trastuzumab (Herceptin)FDA Link
01/2024 - 11/2010
35Hormones (Hormone)IBA
01/2024 - 09/2006
23human ERBB2 proteinIBA
01/2024 - 01/2012
23Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2004
23Docetaxel (Taxotere)FDA Link
10/2023 - 08/2005
21Lapatinib (GW572016)FDA Link
11/2021 - 11/2010
20AnthracyclinesIBA
04/2023 - 08/2004
20Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 03/2008
19ErbB Receptors (EGF Receptor)IBA
01/2024 - 09/2006
17taxaneIBA
12/2023 - 08/2004
16Estrogen ReceptorsIBA
03/2024 - 09/2006
15Capecitabine (Xeloda)FDA Link
01/2022 - 08/2004
14Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2003
11neratinibIBA
11/2021 - 12/2013
10Ado-Trastuzumab EmtansineIBA
05/2024 - 06/2014
10trastuzumab deruxtecanIBA
05/2024 - 01/2020
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2023 - 02/2005
8GemcitabineFDA Link
01/2022 - 12/2006
8pertuzumabIBA
08/2021 - 01/2012
8TamoxifenFDA LinkGeneric
04/2021 - 08/2016
7PlatinumIBA
01/2024 - 01/2017
7Immune Checkpoint InhibitorsIBA
12/2023 - 11/2019
7Immunoconjugates (Immunoconjugate)IBA
10/2023 - 10/2019
7Doxorubicin (Adriamycin)FDA LinkGeneric
09/2023 - 07/2006
7Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2013
7Letrozole (Femara)FDA LinkGeneric
05/2021 - 11/2010
6Tyrosine Kinase InhibitorsIBA
04/2024 - 11/2014
6Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 08/2004
6Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 06/2004
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2024 - 12/2019
5Fulvestrant (Faslodex)FDA Link
03/2024 - 06/2011
5ipatasertibIBA
12/2023 - 10/2017
5palbociclibIBA
11/2023 - 01/2019
5EverolimusFDA Link
04/2022 - 01/2021
5Carboplatin (JM8)FDA LinkGeneric
01/2022 - 02/2005
5Alanine Transaminase (SGPT)IBA
07/2021 - 09/2011
5Epidermal Growth Factor (EGF)IBA
10/2020 - 07/2011
5DNA (Deoxyribonucleic Acid)IBA
01/2018 - 08/2005
4CytokinesIBA
07/2023 - 06/2013
4pembrolizumabIBA
07/2022 - 04/2019
4Phenobarbital (Luminal)FDA Link
12/2021 - 09/2006
4Leuprolide (Lupron)FDA LinkGeneric
05/2021 - 10/2020
3Aromatase InhibitorsIBA
03/2024 - 08/2021
3Cyclin-Dependent Kinase 4IBA
01/2024 - 08/2021
3Cetuximab (Erbitux)FDA Link
10/2023 - 10/2015
3Monoclonal AntibodiesIBA
10/2023 - 01/2012
3Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2023 - 03/2012
3Irinotecan (Camptosar)FDA LinkGeneric
10/2022 - 01/2019
3Messenger RNA (mRNA)IBA
01/2022 - 11/2016
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2021 - 10/2019

Therapy/Procedure

80Therapeutics
04/2024 - 10/2003
68Drug Therapy (Chemotherapy)
03/2024 - 12/2002
37Neoadjuvant Therapy
01/2024 - 01/2003
29Radiotherapy
01/2024 - 08/2003
29Chemoradiotherapy
10/2022 - 10/2004
14Adjuvant Chemotherapy
01/2022 - 06/2004
11Esophagectomy
10/2022 - 07/2008
11Stents
01/2020 - 03/2002
9Mastectomy (Mammectomy)
01/2022 - 11/2019
8Induction Chemotherapy
01/2022 - 09/2011
8Aftercare (After-Treatment)
01/2022 - 08/2011
7Combination Drug Therapy (Combination Chemotherapy)
11/2017 - 08/2005
6Mammaplasty (Breast Reconstruction)
10/2022 - 11/2019
4Stem Cell Transplantation
09/2005 - 12/2002